Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 0.72 |
| ▸ | MAPT | P10636 | 5/20 | 0.72 |
| ▸ | LMNA | P02545 | 6/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | PRKCA | P17252 | 1/20 | 0.62 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.62 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.62 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | GMNN | O75496 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20516371 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL22187086 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL20512293 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL22986095 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL23581586 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL22420022 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL23568445 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL24305193 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25125676 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL20512295 | 1.00 | MAPK1 (0.72) | MAPK1MAPTLMNAALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1860 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312263-A1 | SKIN CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2025-10-09 | — | — | US | claimed |
| US-20250269034-A1 | TOPICAL TETRACYCLINE COMPOSITIONS | JOURNEY MEDICAL CORP (US) | 2025-08-28 | — | — | US | claimed |
| US-12138311-B2 | Topical tetracycline compositions | JOURNEY MEDICAL CORPORATION (US) | 2024-11-12 | — | — | US | claimed |
| WO-2023110424-A1 | COSMETIC COMPOSITION COMPRISING A BIS-AMINO SILICONE, A CATIONIC SURFACTANT, A FATTY ALCOHOL AND A FATTY ALCOHOL ESTER, COSMETIC TREATMENT PROCESS AND USE | L'OREAL (FR) | 2023-06-22 | — | — | WO | claimed |
| US-20230060379-A1 | FULLERENE AND ITS USE TO MAINTAIN GOOD HEALTH AND TO PROLONG THE EXPECTED LIFESPAN OF MAMMALS | Moussa, Fathi (FR) | 2023-03-02 | — | — | US | claimed |
| US-10946101-B2 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | VYNE THERAPEUTICS INC. (US) | 2021-03-16 | — | — | US | claimed |
| US-20210015927-A1 | SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES | SWK FUNDING LLC | 2021-01-21 | — | — | US | claimed |
| US-20200261586-A1 | TOPICAL TETRACYCLINE COMPOSITIONS | FOAMIX PHARMACEUTICALS LTD. (IL) | 2020-08-20 | — | — | US | claimed |
| US-20190134204-A1 | SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES | SWK FUNDING LLC | 2019-05-09 | — | — | US | claimed |
| US-10238746-B2 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | FOAMIX PHARMACEUTICALS LTD (IL) | 2019-03-26 | — | — | US | claimed |
| US-20100008880-A1 | Clear Cosmetic Compositions And Methods Of Using | ELC MANAGEMENT LLC | 2010-01-14 | — | — | US | claimed |
| US-20090068219-A1 | Anti-wrinkle hormone-type cosmetic composition | 3LAB, INC. (US) | 2009-03-12 | — | — | US | claimed |
| EP-2023886-A2 | CLEAR COSMETIC COMPOSITIONS AND METHODS OF USE | ELC Management LLC (US) | 2009-02-18 | — | — | EP | claimed |
| WO-2007130802-A2 | CLEAR COSMETIC COMPOSITIONS AND METHODS OF USE | ELC MANAGEMENT LLC (US) | 2007-11-15 | — | — | WO | claimed |
| US-20070259012-A1 | Clear Cosmetic Compositions and Methods Of Use | CASTRO JOHN | 2007-11-08 | — | — | US | claimed |
| US-20050069511-A1 | Cosmetic compositions containing a starch and an ester and the use thereof | L'OREAL (FR) | 2005-03-31 | — | — | US | claimed |
| EP-1395234-A1 | COSMETIC COMPOSITIONS CONTAINING A STARCH AND AN ESTER AND THE USE THEREOF | L'OREAL (FR) | 2004-03-10 | — | — | EP | claimed |
| US-6589519-B1 | Smoothness, softness; shampoo | L'OREAL S.A. (FR) | 2003-07-08 | — | — | US | claimed |
| EP-1009366-B1 | COSMETIC COMPOSITIONS COMPRISING A POLYOXYALKYLATED AMINATED SILICONE BLOCK POLYMER AND A CONDITIONING AGENT AND THEIR USE | OREAL (FR) | 2003-03-26 | — | — | EP | claimed |
| WO-2002094207-A1 | COSMETIC COMPOSITIONS CONTAINING A STARCH AND AN ESTER AND THE USE THEREOF | L'OREAL (FR) | 2002-11-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050069511-A1 | Cosmetic compositions containing a starch and an ester and the use thereof | CUTA, H1-10, C1S | MAPK1 1719/4885MAPT 1625/4885LMNA 806/4885 |
| US-20250312263-A1 | SKIN CARE COMPOSITIONS | CUTA, CD44, DSG1 | MAPK1 1692/4885MAPT 2493/4885LMNA 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.